Ukraine flag

The Ukraine crisis – an ethical dilemma for the life science...

Russia's inhumane invasion of Ukraine is putting pressure on the life science sector. The major pharmaceutical companies are now pausing clinical studies and other...

Iconovo’s new collaboration aims to optimise current inhalation products

British CrystecPharma begins a collaboration with the Swedish inhaler developer Iconovo with the aim of formulating new innovative compounds for use in dry powder...

Scandion Oncology ready for phase II with SCO-101

Scandion Oncology’s candidate SCO-101 is being developed to fight resistance to cancer drugs and is ready to enter phase II clinical trials. Metastatic colorectal...

Aptahem on the potential for collaboration with the US military

Aptahem has been listed as a member of the American MTEC, a consortium that cooperates with the U.S. Army Medical Research and Material Command...

Stayble Therapeutics has initiated the phase IIb study in Spain

Stayble Therapeutics has now initiated the first clinic in Spain for its clinical phase IIb study with the drug candidate STA363 for chronic disc-related...

Interview with CombiGene’s new CMC expert

The Swedish Gene Therapy Company CombiGene aims to complete its preclinical program for the epilepsy project CG01 this year, in order to begin studies...

DanCann’s CEO predicts a news-intensive spring

Strengthened by a unique pilot project for medical cannabis in Denmark, and with the help of artificial intelligence and cultivation technology developed by NASA,...

Spago Nanomedical on the oversubscribed rights issue and the plan ahead

Recently, Spago Nanomedical announced the outcome of the completed rights issue aimed at investing in their cancer treatment project Tumorad. The high interest –...

Saniona’s Chief Communications Officer on the importance of communication

Throughout 2020, Saniona strengthened its executive team with the recruitment of key leaders in areas such as clinical development, finance and communications. This team...

Gabather – focus on CNS diseases

Diseases of the central nervous system (CNS) and mental health issues represent a major burden on society, and there is considerable room for improvements...